Albert David DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.81×	−2.85×	0.68×	0.78×	0.71×
	1.63×	−0.12×	−6.40×	2.43×	1.42×
	4.7%	−1.3%	−1.1%	11.1%	10.5%
	0.65×	0.65×	0.69×	0.79×	0.83×
	1.33×	1.33×	1.30×	1.30×	1.36×
	5.3%	−0.4%	4.5%	21.4%	11.9%
	−0.4%	−0.4%	4.4%	21.7%	12.2%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

ALBERTDAVD₹767.95

Albert David Limited

· Pharma & Health

₹ CrorePeersVALIANTLAB HALEOSLABS ZIMLAB MEDICO MEDICAMEQ ANUHPHR AHCL WANBURYMcap ₹438 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.71	0.78	0.68	-2.85	0.81
Interest Burden (Pretax/EBIT) ×	1.42	2.43	-6.40	-0.12	1.63
EBIT Margin %	10.48	11.05	-1.14	-1.29	4.69
Asset Turnover ×	0.83	0.79	0.69	0.65	0.65
Financial Leverage (Assets/Equity) ×	1.36	1.30	1.30	1.33	1.33
ROE (5-step product, year-end total equity) %	11.95	21.37	4.47	-0.39	5.34
ROE (owners' profit / average owners' equity) %	12.24	21.72	4.44	-0.38	-0.38

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.